AXA Framlington Biotech Fund - Z Acc
This fund can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Asset allocation %
Morningstar style box TM
Equity style
SizeLarge
Mid
Small
Value
Blend
Growth
Style
Size
| Share class size (mil) | 265 GBP (16/06/2025) |
| Fund size (mil) | 403 GBP (31/10/2024) |
Top 10 holdings
| Assets in top 10 holdings % | 53.69 |
| Total number of equity holdings | 50 |
| Total number of bond holdings | 0 |
| Holdings 31/05/2025 | % of assets |
|---|---|
| Vertex Pharmaceuticals Inc | 8.25 |
| Amgen Inc | 7.70 |
| AstraZeneca PLC ADR | 7.08 |
| Regeneron Pharmaceuticals Inc | 6.54 |
| Gilead Sciences Inc | 5.62 |
| Alnylam Pharmaceuticals Inc | 4.85 |
| argenx SE ADR | 4.28 |
| Neurocrine Biosciences Inc | 3.40 |
| Insmed Inc | 3.20 |
| United Therapeutics Corp | 2.78 |